Dr. Lok reported that she is an adviser or reviewer for Bristol-Myers Squibb, Gilead, Merck, Roche, Abbott, Bayer, and GlaxoSmithKline, and that she receives research or grant support from Bristol-Myers Squibb, Gilead, Merck, Roche, and GlaxoSmithKline.
News
Entecavir Monotherapy Suffices in Many Cases of Chronic Hepatitis B
Publish date: December 23, 2011
FROM THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES